HCMT
SGMO

Highland Capital Management (Texas)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Highland Capital Management (Texas)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-39,734
Closed -$417K – 225
2013
Q3 		$417K Buy
+39,734
New +$395K 0.03% 154

Other funds holding SGMO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Highland Capital Management (Texas)'s SGMO Position: Q4 2013 in Review

Highland Capital Management (Texas) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2013, closing a stake of 39,734 shares — an estimated $417K sold.

Highland Capital Management (Texas) first reported a position in SGMO in Q3 2013 and held it in 1 quarter. The position peaked at $417K in Q3 2013. 115 funds tracked by Wall St. Rank hold SGMO as of Q4 2013.

  • Highland Capital Management (Texas) reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2013 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 39,734 SANGAMO THERAPEUTICS INC shares in Q4 2013, an estimated $417K.
  • Highland Capital Management (Texas) first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s SANGAMO THERAPEUTICS INC position peaked at $417K in Q3 2013.
  • 115 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2013.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2013, filed 14 Feb 2014.